Wuhan Ruixing Biotechnology Co., Ltd., founded in May 2021 and headquartered at 1-2/F, Building 18, Phase 2, Biopharmaceutical Enterprise Accelerator, No. 388, Gaoxin 2nd Road, East Lake New Technology Development Zone, Wuhan, Hubei Province, is a high-tech biotechnology company focused on translating high-throughput sequencing technology into scientific discoveries and industrial applications.
The company boasts over 100 professionals, comprising a comprehensive service team encompassing the Science Department, Analysis Department, Laboratory, Business Department, Marketing Department, and General Management Department. Within our 2,200 square meters of modern office and laboratory space, we uphold our vision of “Blessing the World with Science” and practice our core culture of “First-Class Professionalism, First-Class Service, Love, and Innovation.”
Relying on the team’s 14 years of deep industry cultivation and technological accumulation, we have established close cooperation with more than 500 scientific research institutes, universities and medical institutions in more than 30 provinces and cities across the country. We have supported more than 7,000 scientific research project collaborations, helped customers publish more than 600 SCI papers, and the total impact factor exceeded 3,500+. We have built cutting-edge omics platforms such as single-cell spatial omics and third-generation sequencing, and continue to empower medical health, agricultural breeding, ecological restoration, biomedicine and other fields, blessing the world with science and promoting innovative biotechnology achievements to benefit society.
